Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LIPOCINE-INC-16085349/news/Lipocine-Announces-Confirmation-of-Dosing-Regimen-for-Pivotal-Study-of-LPCN-1154-45893605/?utm_source=whatsapp&utm_medium=social&utm_campaign=share